Skip to main content
Caplight Logo









Hangzhou ConVerd Co., Ltd.

Hangzhou ConVerd Co., Ltd.

Private
HangzhouHealthcare & Life Scienceshttps://converd.com.cn/

Last Round

Strategic

Sep 15, 2017

Total Funding Raised

$4.6M

Company Overview

Hangzhou ConVerd Co., Ltd. is a biotechnology company focused on the research and development of oncolytic viruses and other cancer immunotherapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

oncolytic viruscancer immunotherapyOV therapysolid tumor treatmentbiotechnologydrug discoveryvaccinia virusadenovirusHSVcell therapyclinical trialsbiopharmacold tumor therapyviral vectorbiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Hangzhou ConVerd Co., Ltd. Comparables

Compare Hangzhou ConVerd Co., Ltd. with similar companies based on industry and business-model similarity.

Hangzhou ConVerd Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Wuhan Binhui Biopharmaceutical Co., Ltd.
88%
Virogin Biotech
84%
ImmVira
83%

Hangzhou ConVerd Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicSep 15, 2017

Hangzhou ConVerd Co., Ltd. Investors

Notable investors and investment history

Hangzhou ConVerd Co., Ltd. investors
InvestorRounds
China ResourcesStrategic
Morningside GroupStrategic

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 24, 2026

    Monthly visitors grew 399% MoM.

  • Nov 9, 2025

    Monthly visitors increased 87% MoM.

Hangzhou ConVerd Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

Hangzhou ConVerd Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Hangzhou ConVerd Co., Ltd.'s valuation, stock price, and market status.

Is Hangzhou ConVerd Co., Ltd. a public or private company?

Hangzhou ConVerd Co., Ltd. is a private company.

What is the current stock price of Hangzhou ConVerd Co., Ltd.?

Hangzhou ConVerd Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.

How much is Hangzhou ConVerd Co., Ltd. worth (valuation)?

Valuation information for Hangzhou ConVerd Co., Ltd. is not publicly available.

Can I buy Hangzhou ConVerd Co., Ltd. stock?

Hangzhou ConVerd Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Hangzhou ConVerd Co., Ltd.'s last funding round?

Hangzhou ConVerd Co., Ltd.'s most recent funding round was Strategic on September 15, 2017.

Who are the main investors in Hangzhou ConVerd Co., Ltd.?

Key investors in Hangzhou ConVerd Co., Ltd. include China Resources, Morningside Group.

Will Hangzhou ConVerd Co., Ltd. IPO soon?

No public IPO plans have been announced for Hangzhou ConVerd Co., Ltd..

How can I track Hangzhou ConVerd Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Hangzhou ConVerd Co., Ltd.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHangzhou
Employee Range2
Year Founded2012
Last FundingSep 15, 2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?